EMV
vs
S
S&P/ASX 300
EMV
Over the past 12 months, EMV has underperformed S&P/ASX 300, delivering a return of -5% compared to the S&P/ASX 300's +5% growth.
Stocks Performance
EMV vs S&P/ASX 300
Performance Gap
EMV vs S&P/ASX 300
Performance By Year
EMV vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
